Beyond Air, Inc. XAIR

FY2026 · ended Mar 31, 2026 · Revenue $7.68M, +107.3% YoY · Filed Jun 26, 2026

Beyond Air, Inc. (XAIR) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2026, which ended Mar 31, 2026, it reported revenue of $7.7 million and a net loss of $33.2 million. Free cash flow was -$19.2 million. As of Jun 30, 2026 it held $9.8 million in cash and investments and $1.2 million in total debt.

Revenue (TTM)
$7.69M
Net income (TTM)
$-33.49M
Operating cash flow (TTM)
$-18.56M
Free cash flow (TTM)
$-19.60M
EPS (TTM)
$-3.98
Dividend per share
None
Shares outstanding
14.41M
-84.5% vs prior year
Net cash
$8.61M
as of Jun 30, 2026
Operating margin
-364.8%
FY 2027

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
XAIR (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
Garden City, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1641631
Former names
AIT Therapeutics, Inc. (until Jun 18, 2019); KokiCare, Inc. (until Dec 16, 2016)

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2026
Mar 31, 2026
FY 2025
Mar 31, 2025
FY 2024
Mar 31, 2024
FY 2023
Mar 31, 2023
FY 2022
Mar 31, 2022
Revenue
$7.7M
$3.7M
$1.2M
—
—
Operating income
-$29.0M
-$44.5M
-$63.0M
-$52.1M
-$40.7M
Net income
-$33.2M
-$46.6M
-$60.2M
-$55.8M
-$43.2M
Diluted EPS
-$4.01
-$13.77
-$1.82
—
—
Operating cash flow
-$18.1M
-$38.2M
-$56.0M
-$33.0M
-$23.1M
Free cash flow
-$19.2M
-$44.1M
-$61.8M
-$36.9M
-$24.5M
Total assets
$35.4M
$30.1M
$57.0M
$68.7M
$99.2M
Total liabilities
$29.2M
$15.7M
$29.8M
$26.7M
$21.0M
Stockholders' equity
$6.1M
$13.6M
$25.0M
$37.9M
$72.7M
Cash and investments
$11.6M
$6.9M
$34.5M
$45.9M
$80.2M
Total debt
$1.3M
$1.9M
$19.8M
$2.9M
$2.6M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Results of operations, Regulation FD disclosure
Oct 8, 2026 Oct 8, 2026
8-K Current report
Material agreement, Officer or director change
Sep 24, 2026 Sep 23, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 18, 2026 Aug 13, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Other events
Aug 6, 2026 Aug 6, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 31, 2026 Jul 29, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.